Statewide
Maryland Institute for Emergency Medical Services Systems
Drugs and doses75
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Amoxicillin-Clavulanate, Aspirin, Atropine, Buprenorphine, Caffeine, Calcium Chloride, Calcium Gluconate, Cefazolin, Cephalexin, Cetirizine, Ciprofloxacin, Clindamycin17
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 650 mg | PO | not captured | standing | pages 211, 221 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | pages 211, 221 |
| Other | adult | 640 mg | PO | not captured | standing | page 500 |
| Other | adult | 650–1000 mg | PO | not captured | standing | pages 377, 378, 384 |
| Other | peds | 1.25 mL | PO | not captured | standing | page 211 |
| Other | peds | 2.5 mL | PO | not captured | standing | page 211 |
| Other | peds | 3.75 mL | PO | not captured | standing | page 211 |
| Mild to moderate pain | adult | 650 mg | PO | not captured | standing | pages 211, 221 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 211, 221 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 212 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 212 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 62, 223 |
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 223 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 223 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | peds | 1.25 mg | NEB | not captured | standing | pages 114, 115, 224, 225 |
| Other | adult | 2 puff | NEB | not captured | standing | pages 102, 103 |
| Other | adult | 2.5 mg | NEB | not captured | standing | pages 102, 103, 104 |
| Other | peds | 1.25 mg | NEB | not captured | standing | pages 102, 103, 104 |
| Other | peds | 2 puff | NEB | not captured | standing | page 106 |
| Other | peds | 2 puff | NEB | not captured | standing | pages 102, 103 |
| Other | peds | 2.5 mg | NEB | not captured | standing | pages 103, 104 |
| Respiratory distress | adult | 2 puff | MDI | not captured | standing | pages 102, 103, 146, 147 |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | pages 102, 103, 146, 147 |
| Respiratory distress | peds | 1.25 mg | NEB | not captured | standing | pages 102, 103, 146, 147 |
| Respiratory distress | peds | 2 puff | MDI | not captured | standing | pages 102, 103, 146, 147 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 60, 227 |
| Other | adult | 150 mg | IV/IO | not captured | standing | page 60 |
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 66, 227 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 66, 227 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 60, 227 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 62 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 66 |
Amoxicillin-Clavulanate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 tablet | PO | not captured | standing | page 501 |
| Other | adult | 1 tablet | PO | every 8 hours | standing | page 501 |
| Other | adult | 500 mg | PO | every 8 hours | standing | page 485 |
| Other | peds | 10 mg/kg | PO | not captured | standing | page 501 |
| Other | peds | 10 mg/kg | PO | every 12 hours | standing | page 501 |
| Other | peds | 10 mg/kg | PO | every 8 hours | standing | page 485 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 89, 214, 228 |
| Other | adult | 324 mg | PO | not captured | standing | pages 89, 214, 228, 484 |
| Other | adult | 324 mg | PO | not captured | standing | pages 214, 228 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5–1 mg | IV | not captured | standing | pages 56, 58, 230 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | pages 56, 58, 230 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 58, 230 |
| Bradycardia | peds | 0.04–0.06 mg/kg | ET | not captured | standing | pages 58, 69, 230 |
| Organophosphate poisoning | adult | 2–4 mg | IV/IM | not captured | standing | pages 164, 230 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IM | not captured | standing | pages 164, 230 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO/IM | not captured | standing | pages 166, 230 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | pages 415, 417 |
Caffeine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 200 mg | PO | not captured | standing | page 465 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 0.5–1 g | IV/IO | not captured | standing | page 231 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 231 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 114, 115, 231 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | pages 114, 115, 231 |
| Hypotension / shock | adult | 500 mg | IV/IO | not captured | standing | page 231 |
| Other | adult | 0.5–1 g | IV/IO | not captured | standing | page 231 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 65 |
| Other | adult | 500 mg | IV/IO | not captured | standing | page 231 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 231 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 58 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | pages 115, 231 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mL | IV/IO | not captured | standing | page 511 |
| Other | adult | 3 g | IV/IO | not captured | standing | pages 395, 396, 397 |
| Other | adult | 3 g | IV/IO | not captured | standing | pages 395, 396, 397 |
| Other | adult | 4 mL | NEB | not captured | standing | pages 395, 396 |
| Other | adult | 4 mL | NEB | not captured | standing | pages 395, 396 |
| Other | peds | 60 mg/kg | IV/IO | not captured | standing | pages 395, 396, 397 |
| Other | peds | 60 mg/kg | IV/IO | not captured | standing | pages 395, 396, 397 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IO | not captured | standing | pages 180, 182, 184, 232, 401 |
| Other | peds | 1 g | IV/IO | not captured | standing | pages 180, 182, 184, 232, 401 |
| Other | peds | 500 mg | IV/IO | not captured | standing | pages 180, 184, 232, 401 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 180, 232 |
| Trauma / hemorrhage | peds | 500 mg | IV/IO | not captured | standing | pages 180, 232 |
Cephalexin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500 mg | PO | every 6 hours | standing | page 502 |
| Other | peds | 10 mg/kg | PO | every 6 hours | standing | page 502 |
Cetirizine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 10 mg | PO | not captured | standing | page 454 |
Ciprofloxacin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500 mg | PO | every 12 hours | standing | page 502 |
Clindamycin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | PO | every 8 hours | standing | page 460 |
| Other | peds | 10 mg/kg | PO | every 8 hours | standing | page 460 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Dimenhydrinate, Diphenhydramine, Dopamine, Doxycycline, Droperidol, Emtricitabine And Tenofovir, Epinephrine, Esmolol, Etomidate, Famotidine, Fentanyl15
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 15 mg | IV/IO/IM | not captured | standing | pages 105, 233 |
| Anaphylaxis | peds | 0.5 mg/kg | IV/IO/IM | not captured | standing | pages 105, 233 |
| Asthma / bronchospasm | adult | 15 mg | IV/IM/PO | not captured | standing | pages 146, 233 |
| Asthma / bronchospasm | peds | 0.5 mg/kg | IV/IM/PO | not captured | standing | pages 146, 233 |
| Asthma / bronchospasm | peds | 0.5 mg/kg | IV/IM/PO | not captured | standing | page 233 |
| Croup | adult | 15 mg | IV/IM/PO | not captured | standing | pages 153, 233 |
| Croup | peds | 0.5 mg/kg | IV/IM/PO | not captured | standing | pages 153, 233 |
| Other | adult | 15 mg | IV/IM | not captured | standing | page 385 |
| Other | adult | 15 mg | IV | not captured | standing | page 503 |
| Other | adult | 16 mg | PO | not captured | standing | page 503 |
| Other | peds | 0.5 mg/kg | IV/IM/PO | not captured | standing | page 147 |
| Other | peds | 0.5 mg/kg | PO | not captured | standing | page 153 |
| Other | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 153 |
| Other | peds | 0.5 mg/kg | IV | not captured | standing | page 503 |
| Other | peds | 16 mg | PO | not captured | standing | page 503 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 113, 234, 235 |
| Hypoglycemia | peds | 2–4 mL/kg | IV/IO | not captured | standing | pages 113, 234, 235 |
| Other | adult | 10–15 g | PO | not captured | standing | pages 113, 122, 123 |
| Other | adult | 50 mL | IV/IO | not captured | standing | pages 113, 234 |
| Other | adult | 25 g | IV/IO | not captured | standing | pages 113, 234 |
| Other | adult | 50 mL | IV/IO | not captured | standing | page 401 |
| Other | peds | 10–15 g | PO | not captured | standing | pages 113, 122, 123 |
| Other | peds | 2 mL/kg | IV/IO | not captured | standing | pages 113, 234 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 10 mg | IM | not captured | standing | page 236 |
| Nerve agent exposure | peds | 0.1 mg/kg | IM | not captured | standing | page 236 |
| Seizure | adult | 2.5–10 mg | IV/IM | not captured | standing | page 236 |
| Seizure | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 236 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 236 |
| Seizure | peds | 0.2 mg/kg | PR | not captured | standing | page 236 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | pages 60, 237 |
| Other | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 60 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 237 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 401 |
| Other | adult | 5–10 mg | IV | not captured | standing | pages 237, 238 |
Dimenhydrinate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 50–100 mg | IV/IM/PO | not captured | standing | page 456 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IM | not captured | standing | pages 102, 103, 104, 239 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | pages 102, 103, 104, 239 |
| Anaphylaxis | adult | 50 mg | IV/IM | not captured | standing | pages 105, 106 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | pages 105, 106 |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | standing | pages 96, 98, 239, 242 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | pages 96, 98, 239, 242 |
| Other | adult | 25 mg | IV/IM | not captured | standing | page 102 |
| Other | adult | 25–50 mg | IV/IM | not captured | standing | pages 96, 98 |
| Other | adult | 50 mg | IV/IM | not captured | standing | pages 102, 104 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | pages 96, 98 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | pages 102, 104 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 239 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2–20 mcg/kg | IV | not captured | standing | pages 240, 241 |
| Anaphylaxis | peds | 2–20 mcg/kg | IV | not captured | standing | pages 240, 241 |
| Cardiogenic shock | adult | 2–20 mcg/kg | IV | not captured | standing | pages 240, 241 |
| Cardiogenic shock | peds | 2–20 mcg/kg | IV | not captured | standing | pages 240, 241 |
| Other | peds | 2–20 mcg/kg | IV | not captured | standing | page 241 |
| Sepsis | adult | 2–20 mcg/kg | IV | not captured | standing | pages 240, 241 |
| Sepsis | peds | 2–20 mcg/kg | IV | not captured | standing | pages 240, 241 |
| Trauma / hemorrhage | adult | 2–20 mcg/kg | IV | not captured | standing | pages 240, 241 |
| Trauma / hemorrhage | peds | 2–20 mcg/kg | IV | not captured | standing | pages 240, 241 |
Doxycycline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | PO | not captured | standing | pages 461, 497, 503 |
| Other | adult | 100 mg | PO | not captured | standing | page 497 |
| Other | adult | 200 mg | PO | not captured | standing | pages 497, 503 |
| Other | peds | 2.2 mg/kg | PO | not captured | standing | pages 461, 497, 503 |
| Other | peds | 2.2 mg/kg | PO | not captured | standing | page 497 |
| Other | peds | 4.4 mg/kg | PO | not captured | standing | pages 497, 503 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IM | not captured | standing | pages 96, 97, 98, 242, 243 |
| Agitation | peds | 2.5 mg | IV/IM | not captured | standing | pages 96, 97, 98, 242, 243 |
| Nausea / vomiting | adult | 1.25 mg | IV/IM | not captured | standing | pages 116, 117, 242, 243 |
| Other | adult | 1.25 mg | IV/IM | not captured | standing | pages 116, 117, 243 |
| Other | peds | 1.25 mg | IV/IM | not captured | standing | pages 116, 117, 243 |
Emtricitabine And Tenofovir
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 tablet | PO | not captured | standing | page 461 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | pages 102, 103, 104, 105, 106, 107, 215, 216, 246 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 102, 103, 104, 105, 106, 107, 215, 216, 246 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 56, 57, 58, 245, 246 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 56, 57, 58, 245, 246 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 65, 71, 245 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 65, 71, 245 |
| Other | adult | 0.3 mg | IM | not captured | standing | pages 102, 216 |
| Other | adult | 0.5 mg | IM | not captured | standing | pages 102, 215, 246 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 245, 246 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 246 |
| Other | peds | 0.03 mg/kg | ET | not captured | standing | page 246 |
| Other | peds | 0.1 mg | IV/IO | not captured | standing | pages 71, 245 |
| Other | peds | 0.15 mg | IV/IO | not captured | standing | pages 71, 245 |
| Other | peds | 0.15 mg | IM | not captured | standing | pages 103, 104, 215, 216, 246 |
| Other | peds | 0.3 mg | IV/IO | not captured | standing | pages 71, 245 |
| Other | peds | 0.3 mg | IM | not captured | standing | pages 103, 216 |
| Other | peds | 0.5 mg | IV/IO | not captured | standing | pages 71, 245 |
| Other | peds | 0.5 mg | IM | not captured | standing | pages 103, 104, 215, 246 |
| Other | peds | 2.5 mL | NEB | not captured | standing | page 246 |
Esmolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IV/IO | not captured | standing | pages 67, 248 |
| VF / pulseless VT | adult | 0.5 mg/kg | IV/IO | not captured | standing | pages 67, 248 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 423, 435 |
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 426, 432, 435 |
| Other | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 423, 435 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 20 mg | PO | not captured | standing | page 493 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 119, 250 |
| Other | adult | 1 mcg/kg | IV/IM/IN | not captured | standing | pages 500, 504 |
| Other | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 121, 250 |
| Other | peds | 1 mcg/kg | IV/IM/IN | not captured | standing | pages 500, 504 |
| Severe pain | adult | 1 mcg/kg (max 200 mcg) | IV/IO/IM/IN | not captured | standing | pages 119, 121, 250 |
| Severe pain | peds | 1 mcg/kg (max 200 mcg) | IV/IO/IM/IN | not captured | standing | pages 119, 121, 250 |
G–L Glucagon, Haloperidol, Hydroxocobalamin, Hypertonic Saline, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Loperamide11
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV | not captured | standing | page 251 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV | not captured | standing | pages 164, 166, 251 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV | not captured | standing | page 251 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 1 mg | IV | not captured | standing | pages 164, 166, 251 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 113, 251 |
| Hypoglycemia | peds | 0.5 mg | IM/IN | not captured | standing | pages 113, 251 |
| Other | adult | 1 mg | IM/IN | not captured | standing | pages 113, 235, 251 |
| Other | adult | 1 mg | IM | not captured | standing | page 486 |
| Other | peds | 0.5 mg | IM | not captured | standing | page 486 |
| Other | peds | 1 mg | IM/IN | not captured | standing | pages 113, 235, 251 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IM | not captured | standing | page 252 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 252 |
| Agitation | peds | 0.05 mg/kg (max 2.5 mg) | IM | not captured | standing | page 252 |
| Agitation | peds | 2.5–5 mg | IM | not captured | standing | page 252 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 370, 372 |
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 370, 372 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | pages 370, 372 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | pages 370, 372 |
Hypertonic Saline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mL | IV/IO | not captured | standing | page 505 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 400–600 mg | PO | not captured | standing | page 377 |
| Other | adult | 400–600 mg | PO | not captured | standing | page 487 |
| Other | adult | 600–800 mg | PO | not captured | standing | page 377 |
| Other | peds | 200–400 mg | PO | not captured | standing | page 487 |
| Mild to moderate pain | adult | 200 mg | PO | not captured | standing | pages 118, 121, 487, 505 |
| Mild to moderate pain | adult | 600 mg | PO | not captured | standing | page 500 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 118, 121, 487, 505 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 500 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 500 mcg | NEB | not captured | standing | page 105 |
| Anaphylaxis | peds | 250 mcg | NEB | not captured | standing | page 106 |
| Anaphylaxis | peds | 500 mcg | NEB | not captured | standing | page 106 |
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | pages 146, 147, 253, 254 |
| Asthma / bronchospasm | peds | 250 mcg | NEB | not captured | standing | pages 146, 147, 253, 254 |
| Other | adult | 500 mcg | NEB | not captured | standing | pages 102, 104, 105, 106, 253, 254 |
| Other | adult | 500 mcg | NEB | not captured | standing | page 253 |
| Other | adult | 500 mcg | NEB | not captured | standing | page 102 |
| Other | adult | 500 mcg | NEB | not captured | standing | pages 253, 254 |
| Other | peds | 250 mcg | NEB | not captured | standing | page 104 |
| Other | peds | 250 mcg | NEB | not captured | standing | pages 102, 104, 105, 106, 253, 254 |
| Other | peds | 250 mcg | NEB | not captured | standing | pages 253, 254 |
| Other | peds | 500 mcg | NEB | not captured | standing | page 104 |
| Other | peds | 500 mcg | NEB | not captured | standing | page 254 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO | not captured | standing | pages 96, 98, 256, 257 |
| Agitation | adult | 4 mg/kg | IM | not captured | standing | pages 96, 98, 256, 257 |
| Agitation | peds | 1 mg/kg | IV/IO | not captured | standing | pages 96, 98, 256, 257 |
| Agitation | peds | 4 mg/kg | IM | not captured | standing | pages 96, 98, 256, 257 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 257 |
| Severe pain | adult | 0.2 mg/kg | IV/IO | not captured | standing | pages 119, 121, 256 |
| Severe pain | adult | 0.5 mg/kg | IM/IN | not captured | standing | pages 119, 121, 256 |
| Severe pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 119, 121, 256 |
| Severe pain | peds | 0.5 mg/kg | IM/IN | not captured | standing | pages 119, 121, 256 |
| Post-intubation sedation | adult | 2 mg/kg | IV/IO | not captured | standing | pages 257, 426, 432 |
| Post-intubation sedation | peds | 2 mg/kg | IV/IO | not captured | standing | pages 257, 426, 432 |
| Seizure | adult | 1 mg/kg | IV/IO | not captured | standing | pages 122, 123, 257 |
| Seizure | adult | 2 mg/kg | IM/IN | not captured | standing | pages 122, 123, 257 |
| Seizure | peds | 1 mg/kg | IV/IO | not captured | standing | pages 122, 123, 257 |
| Seizure | peds | 1 mg/kg | IM/IN | not captured | standing | pages 122, 123, 257 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg | IV/IM | not captured | standing | page 381 |
| Severe pain | adult | 15 mg | IV | not captured | standing | pages 119, 121, 258, 259 |
| Severe pain | adult | 30 mg | IM | not captured | standing | pages 119, 121, 258, 259 |
| Severe pain | peds | 0.5 mg/kg (max 15 mg) | IV | not captured | standing | pages 119, 121, 258, 259 |
| Severe pain | peds | 1 mg/kg (max 30 mg) | IM | not captured | standing | pages 119, 121, 258, 259 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV/IO | not captured | standing | pages 260, 261 |
| Stroke | adult | 10 mg | IV/IO | not captured | standing | pages 4, 134, 261 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 385 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 385 |
| Other | adult | 20–40 mg | IO | not captured | standing | pages 265, 317 |
| Other | adult | 20–40 mg | IO | not captured | standing | pages 265, 317 |
| Other | adult | 40 mg | IN | not captured | standing | page 265 |
| Other | peds | 10 mg | IO | not captured | standing | pages 265, 317 |
| Other | peds | 10–20 mg | IO | not captured | standing | pages 265, 317 |
| Other | peds | 20 mg | IO | not captured | standing | pages 265, 317 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 265 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 265 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 265 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 265 |
Loperamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mg | PO | not captured | standing | page 505 |
| Other | adult | 4 mg | PO | not captured | standing | page 499 |
| Other | peds | 2 mg | PO | not captured | standing | page 505 |
| Other | peds | 2 mg | PO | not captured | standing | page 499 |
M–O Magnesium Sulfate, Meclizine, Metoclopramide, Metoprolol, Midazolam, Modafinil, Morphine, Naloxone, Naproxen, Nerve Agent Antidote Kit, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose, Oxycodone, Oxymetazoline16
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | pages 145, 267 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | pages 146, 267 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | pages 146, 148, 267 |
| Other | adult | 4 g | IV/IO | not captured | standing | pages 144, 267 |
| Other | adult | 4 g | IV/IO | not captured | standing | pages 122, 123 |
| Other | peds | 4 g | IV/IO | not captured | standing | pages 122, 123 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | pages 146, 267 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | pages 146, 148, 267 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | pages 66, 267 |
| Wide-complex tachycardia | peds | 25 mg/kg | IV/IO | not captured | standing | pages 66, 267 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 66 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 66, 267 |
| VF / pulseless VT | peds | 25 mg/kg | IV/IO | not captured | standing | pages 66, 267 |
Meclizine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 mg | PO | not captured | standing | pages 383, 457 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 10–20 mg | IV/IM/PO | not captured | standing | page 456 |
| Other | adult | 10 mg | PO | not captured | standing | page 505 |
| Other | peds | 0.1 mg/kg | PO | not captured | standing | page 505 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV/IO | not captured | standing | page 268 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 268 |
| Other | adult | 5 mg | IV | not captured | standing | page 268 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 5 mg | IM | not captured | standing | page 271 |
| Other | adult | 0.1 mg/kg | IV/IM | not captured | standing | page 272 |
| Other | adult | 0.1 mg/kg | IV | not captured | standing | pages 57, 58 |
| Other | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 90 |
| Other | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 90 |
| Other | adult | 0.1 mg/kg | IV | not captured | standing | page 272 |
| Other | adult | 2–2.5 mg | IV | not captured | standing | pages 101, 272 |
| Other | adult | 2.5 mg | IV/IO | not captured | standing | pages 271, 272 |
| Other | adult | 5 mg | IV/IM | not captured | standing | pages 96, 98, 271 |
| Other | adult | 5 mg | IM/IN | not captured | standing | pages 101, 272 |
| Other | adult | 5 mg | IM | not captured | standing | pages 271, 272 |
| Other | adult | 5 mg | IM/IN | not captured | standing | page 271 |
| Other | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 272 |
| Other | peds | 0.05 mg/kg | IV | not captured | standing | page 272 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 96, 98, 271 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 57, 58 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 90 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 90 |
| Other | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | pages 98, 271, 272 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 271 |
| Other | peds | 2.5 mg | IV/IO | not captured | standing | pages 271, 272 |
| Other | peds | 5 mg | IM | not captured | standing | pages 271, 272 |
| Seizure | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 271 |
| Seizure | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 271 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 271 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 271 |
Modafinil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 200 mg | PO | not captured | standing | page 466 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 152, 274 |
| Other | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 119 |
| Other | adult | 0.1 mg/kg | IV/IM | not captured | standing | page 274 |
| Other | adult | 4 mg | IM | not captured | standing | page 506 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 121, 274 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 152, 274 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | page 506 |
| Severe pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 119, 274 |
| Severe pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 119, 274 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4–2 mg | IV/IO/IM/IN | not captured | standing | pages 163, 165, 275 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 163, 165, 275 |
| Other | peds | 0.2–0.25 mg/kg | ET | not captured | standing | pages 165, 275 |
| Other | peds | 2 mg | IN | not captured | standing | pages 163, 165, 217 |
| Respiratory distress | adult | 0.4 mg | IV/IO | not captured | standing | pages 163, 165, 275 |
| Respiratory distress | adult | 0.4 mg | IM | not captured | standing | pages 163, 165, 275 |
| Respiratory distress | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 163, 165, 275 |
| Respiratory distress | peds | 0.1 mg/kg | IM | not captured | standing | pages 163, 165, 275 |
| Respiratory distress | peds | 0.1 mg/kg | IN | not captured | standing | pages 163, 165, 217, 275 |
| Respiratory distress | peds | 0.2 mg/kg | ET | not captured | standing | page 275 |
Naproxen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 220–500 mg | PO | not captured | standing | page 463 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 6 mg | IM | not captured | standing | pages 406, 407 |
| Nerve agent exposure | peds | 2 mg | IM | not captured | standing | pages 406, 407 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 89, 218, 276 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 150, 151, 276, 277 |
| Other | adult | 0.8 mg | SL | not captured | standing | pages 150, 277 |
| Other | adult | 1 inch | TOP | not captured | standing | pages 150, 277, 278 |
| Other | adult | 400 mcg | IV | not captured | standing | pages 361, 362 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mcg/kg | IV | not captured | standing | pages 419, 420 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 8 mg | IV | not captured | standing | pages 116, 117, 279 |
| Nausea / vomiting | adult | 8 mg | ODT | not captured | standing | pages 116, 117, 279 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | pages 116, 117, 279 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | pages 117, 279 |
| Nausea / vomiting | peds | 0.1 mg/kg | IM | not captured | standing | page 279 |
| Nausea / vomiting | peds | 8 mg | ODT | not captured | standing | pages 116, 117, 279 |
| Other | adult | 4 mg | IM | not captured | standing | page 498 |
| Other | adult | 4–8 mg | IM | not captured | standing | pages 116, 279 |
| Other | adult | 4–8 mg | IV/IM | not captured | standing | pages 377, 383 |
| Other | adult | 8 mg | IV/IM/ODT | not captured | standing | pages 116, 117, 279 |
| Other | adult | 8 mg | IV/IM/ODT | not captured | standing | pages 116, 117, 243 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | page 498 |
| Other | peds | 8 mg | IV/IM/ODT | not captured | standing | pages 116, 117, 279 |
| Other | peds | 8 mg | IV/IM/ODT | not captured | standing | pages 116, 117, 243 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 10–15 g | PO | not captured | standing | pages 113, 219 |
| Hypoglycemia | adult | 10–15 g | not captured | not captured | standing | pages 113, 219 |
| Hypoglycemia | peds | 10–15 g | PO | not captured | standing | pages 113, 219 |
| Hypoglycemia | peds | 10–15 g | not captured | not captured | standing | pages 113, 219 |
| Other | adult | 10–15 g | not captured | not captured | standing | pages 122, 123, 512 |
| Other | adult | 10–15 g | not captured | not captured | standing | page 486 |
| Other | peds | 10–15 g | not captured | not captured | standing | pages 122, 123, 512 |
Oxycodone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–10 mg | PO | not captured | standing | page 500 |
| Other | peds | 0.1 mg/kg | PO | not captured | standing | page 500 |
| Severe pain | adult | 1–2 tablet | PO | not captured | standing | page 506 |
| Severe pain | peds | 0.05–0.15 mg/kg | PO | not captured | standing | page 506 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 455 |
P–R Pralidoxime, Prednisone, Promethazine, Proparacaine, Rocuronium5
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | pages 406, 407 |
| Nerve agent exposure | peds | 15 mg/kg | IM | not captured | standing | pages 406, 407 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 40 mg | PO | not captured | standing | page 462 |
| Asthma / bronchospasm | adult | 40 mg | PO | not captured | standing | page 462 |
| COPD | adult | 40 mg | PO | not captured | standing | page 462 |
| Other | adult | 40 mg | PO | not captured | standing | page 462 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 25 mg | PO | not captured | standing | page 498 |
| Nausea / vomiting | peds | 0.5 mg/kg | PO | not captured | standing | page 498 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | OPH | not captured | standing | page 457 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | adult | 1 mg/kg | IV/IO | not captured | standing | page 438 |
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 424, 431, 438 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 424, 431, 438 |
S–Z Scopolamine, Sodium Bicarbonate, Succinylcholine, Terbutaline, Tetracaine, Tramadol, Tranexamic Acid, Trimethoprim-Sulfamethoxazole, Vecuronium, Whole Blood, Zaleplon11
Scopolamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | TD | not captured | standing | pages 383, 457 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 281 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 281 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 114, 115, 281 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 114, 115, 281 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 163, 282 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 65, 66, 71, 281 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | pages 114, 115, 281 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 163, 282 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 65, 66, 71, 281 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 114, 115, 281 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 424, 430, 439 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | pages 424, 430, 439 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.25 mg | IM | not captured | standing | page 283 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | OPH | not captured | standing | page 457 |
| Other | adult | 1–2 drop | OPH | not captured | standing | page 457 |
| Other | adult | 2 drop | OPH | not captured | standing | page 492 |
| Other | peds | 2 drop | OPH | not captured | standing | page 492 |
Tramadol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 50–100 mg | PO | not captured | standing | page 463 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 g | IV/IO | not captured | standing | page 284 |
| Obstetric hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 284 |
| Obstetric hemorrhage | peds | 500 mg | IV/IO | not captured | standing | page 284 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 284 |
| Other | adult | 1 g | IV/IO | not captured | standing | pages 129, 131, 139, 143, 284 |
| Other | peds | 1 g | IV/IO | not captured | standing | pages 129, 131, 139, 143, 284 |
| Other | peds | 500 mg | IV/IO | not captured | standing | page 284 |
Trimethoprim-Sulfamethoxazole
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 5 mg/kg | PO | not captured | standing | page 507 |
| Other | peds | 5 mg/kg | PO | not captured | standing | page 507 |
| Other | peds | 5 mg/kg | PO | not captured | standing | page 507 |
| Other | peds | 5 mg/kg | PO | not captured | standing | page 507 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | adult | 0.05 mg/kg | IV/IO | not captured | standing | pages 433, 440 |
| Post-intubation sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 433, 440 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 424, 431, 440 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 424, 431, 440 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 360 |
| Trauma / hemorrhage | peds | 10 mL/kg | IV/IO | not captured | standing | page 360 |
Zaleplon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | PO | not captured | standing | page 465 |
Cite this
Maryland Institute for Emergency Medical Services Systems, United States EMS Protocol Census. 407 dose entries, effective 2026-07-01.
https://protoquiz.com/census/agencies/maryland-institute-for-emergency-medical-services-systems/
The census is free and not for sale. Only public agencies are named.